• Contact info@abtriva.com for inquiries and orders.
  • Chinese (Simplified)

  • English

  • German

  • Korean

  • Spanish

United States (English / $ USD)

Recombinant Human Probable guanine nucleotide exchange factor MCF2L2 (MCF2L2), Truncated

ACP15389

Number
Order Exclusive Products Now

Request a Quote
High Purity LevelsPrecision and ReliabilityCustomization Options

Specifications


Cat.No ACP15389 Target NameMCF2L2
FormLyophilized powderExpression SystemCustom Production. Please inquire and provide the desire expression system.
Protein LengthPartialPurity>85% (SDS-PAGE)
Storage Buffer5%-50% glycerol. Lyophilized powder form: the buffer before lyophilization is Tris/PBS-based buffer, 6% Trehalose, Liquid form: default storage buffer is Tris/PBS-based buffer, pH 8.0.

Immunogen Information


Target SpeciesHumanUniprot IDQ86YR7
Background Information
  • Uniprot Id

    Q86YR7

  • Target Species

    Human

  • Target Name

    MCF2L2

  • Target Full Name

    Probable guanine nucleotide exchange factor MCF2L2

  • Target Function

    Probably functions as a guanine nucleotide exchange factor.

  • Target Involvement

    Diabetes mellitus, non-insulin-dependent (NIDDM)

  • Target Protein Families

    MCF2 family

  • Target Tissue Specificity

    Significantly expressed in brain and modestly in pancreas, brain and testis.

  • Target Synonyms

    ARHGEF22; Dbs related Rho family guanine nucleotide exchange factor; Dbs-related Rho family guanine nucleotide exchange factor; DKFZp686K0690; DRG; FLJ42509; KIAA0861; MCF.2 cell line derived transforming sequence like 2; MCF2 transforming sequence like protein 2; MCF2-transforming sequence-like protein 2; MCF2L2; MF2L2_HUMAN; Probable guanine nucleotide exchange factor MCF2L2; Rho family guanine nucleotide exchange factor

Inquire Recombinant Human Probable guanine nucleotide exchange factor MCF2L2 (MCF2L2), Truncated Now



AbTriva respects your privacy and protects your personal data in accordance with AbTriva. For more information, please see our data protection statement. *

Notification